Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldsmith

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Blood Purification|January 22, 2010
Magnesium in chronic kidney disease: challenges and opportunitiesMehmet Kanbay, David Goldsmith, Mehtap Erkmen Uyar, et al.
International Urology and Nephrology|March 29, 2008
Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplantMohammad S Khan, Sami Ahmed, Ben Challacombe, et al.
BMC Nephrology|July 28, 2016
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemiaDaniel Eriksson, David Goldsmith, Siguroli Teitsson, et al.
Blood Purification|August 11, 2011
Renal anemia of inflammation: the name is self-explanatoryMahmut Ilker Yilmaz, Yalcin Solak, Adrian Covic, et al.
Clinical Kidney Journal|June 16, 2017
Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patientsOliver J Ziff, Hugo Penny, Sharon Frame, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2015
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and AnemiaDavid M Charytan, Steven Fishbane, Jolanta Malyszko, et al.
Seminars in Nephrology|December 16, 2014
News on biomarkers in CKD-MBDSandro Mazzaferro, Lida Tartaglione, Silverio Rotondi, et al.
Critical Reviews in Oncology/Hematology|December 8, 2022
Epoetin alfa biosimilar (HX575): A review of 15 years' post-approval clinical experiencePere Gascón, David Goldsmith, Matti Aapro, et al.
Transplantation|February 9, 2005
Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathyBehdad Afzali, Sapna Shah, Paramit Chowdhury, et al.
Drug Design, Development and Therapy|January 4, 2018
HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experienceFrank Dellanna, David Goldsmith, Andriy Krendyukov, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Blood Purification|January 22, 2010
Magnesium in chronic kidney disease: challenges and opportunitiesMehmet Kanbay, David Goldsmith, Mehtap Erkmen Uyar, et al.
International Urology and Nephrology|March 29, 2008
Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplantMohammad S Khan, Sami Ahmed, Ben Challacombe, et al.
BMC Nephrology|July 28, 2016
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemiaDaniel Eriksson, David Goldsmith, Siguroli Teitsson, et al.
Blood Purification|August 11, 2011
Renal anemia of inflammation: the name is self-explanatoryMahmut Ilker Yilmaz, Yalcin Solak, Adrian Covic, et al.
Clinical Kidney Journal|June 16, 2017
Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patientsOliver J Ziff, Hugo Penny, Sharon Frame, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2015
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and AnemiaDavid M Charytan, Steven Fishbane, Jolanta Malyszko, et al.
Seminars in Nephrology|December 16, 2014
News on biomarkers in CKD-MBDSandro Mazzaferro, Lida Tartaglione, Silverio Rotondi, et al.
Critical Reviews in Oncology/Hematology|December 8, 2022
Epoetin alfa biosimilar (HX575): A review of 15 years' post-approval clinical experiencePere Gascón, David Goldsmith, Matti Aapro, et al.
Transplantation|February 9, 2005
Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathyBehdad Afzali, Sapna Shah, Paramit Chowdhury, et al.
Drug Design, Development and Therapy|January 4, 2018
HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experienceFrank Dellanna, David Goldsmith, Andriy Krendyukov, et al.
Pageof 19